Analysis of comorbidities and chronically used medications in patients with mild cognitive impairment aged 60–74 years

Mild cognitive impairment (MCI) is a condition that may precede the onset of Alzheimer's disease. Of interest are factors that influence the induction of MCI. In this study, we assessed 92 patients with MCI (aged 60–74 years) and 118 controls for comorbidities and medication. In the MCI group, multimorbidity was observed significantly more often. MCI correlated with age, overweight, multimorbidity, the presence of allergic disease, depression, use of sleep medications and tramadol derivatives. The results indicate a higher possibility of MCI in the 60-year-old group, especially in those with multimorbidity and using certain types of drugs.